Spectranetics Cp T (SPNC) 23.16 $SPNC Spectranetics

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Spectranetics Cp T (SPNC) 23.16 $SPNC

Spectranetics Reports Second Quarter 2016 Revenue of $67.7 million
GlobeNewswire - Thu Jul 28, 3:01PM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months ended June 30, 2016. Highlights of the quarter, all compared with the three months ended June 30, 2015, include:
SPNC: 23.16 (-0.02)

QT Vascular Announces Federal Circuit Reversal of Adverse AngioScore / Spectranetics Judgment
PR Newswire - Mon Jul 25, 7:19AM CDT
QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group" , is a global company engaged in the design, assembly and distribution of advanced therapeutic solutions for the minimally invasive treatment of vascular disease. Further to the Company's announcements of 29 April 2015, 2 July 2015 and 8 July 2015 and media releases of 4 May 2015, 20 September 2015, 26 November 2015 and 11 February 2016, the Board of Directors of the Company is pleased to provide an update in its ongoing litigation with AngioScore, Inc. ("AngioScore" (now owned by Spectranetics Corporation (NASDAQ: SPNC)).
SPNC: 23.16 (-0.02)

Uptrend Call Working As Spectranetics Stock Rises 28.4% (SPNC)
Comtex SmarTrend(R) - Fri Jun 10, 1:00AM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on March 4th, 2016 at $15.43. In approximately 3 months, Spectranetics has returned 28.41% as of today's recent price of $19.82.
SPNC: 23.16 (-0.02)

How are These Healthcare Stocks Faring? - Zimmer Biomet, Wright Medical, Spectranetics and Prestige Brands
PR Newswire - Fri Jun 03, 7:00AM CDT
In today's pre-market coverage, ActiveWallSt.com has these four Medical Appliances and Equipment stocks lined up for investors to review: Zimmer Biomet Holdings Inc. (NYSE: ZBH), Wright Medical Group N.V. (NASDAQ: WMGI), The Spectranetics Corp. (NASDAQ: SPNC), and Prestige Brands Holdings Inc. (NYSE: PBH). Register now to access these stocks' trade alerts by clicking on the following link:
SPNC: 23.16 (-0.02), ZBH: 131.06 (-0.08), WMGI: 21.64 (-0.29), PBH: 53.59 (+0.09), WMGIZ: 1.27 (-0.12)

Shares of SPNC Up 26.3% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Thu Jun 02, 1:55PM CDT
SmarTrend identified an Uptrend for Spectranetics (NASDAQ:SPNC) on March 4th, 2016 at $15.43. In approximately 3 months, Spectranetics has returned 26.27% as of today's recent price of $19.49.
SPNC: 23.16 (-0.02)

Second Interim Analysis on ILLUMENATE Global Study Presented on Spectranetics' Stellarex drug-coated balloon at NCVH
GlobeNewswire - Wed Jun 01, 3:00PM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today announced that Dr. Prakash Krishnan of Mount Sinai Medical Center, New York, NY presented the second interim analysis of 12-month data from the ILLUMENATE Global Study at the New Cardiovascular Horizons annual conference in New Orleans, Louisiana. The ILLUMENATE Global Study is a prospective, multicenter, single-arm study designed to assess the clinical performance of the Stellarex(TM) drug-coated balloon (DCB) in the superficial femoral and popliteal arteries.
SPNC: 23.16 (-0.02)

SmarTrend Watching for Potential Pullback in Shares of Spectranetics After 5.77% Gain
Comtex SmarTrend(R) - Mon May 23, 4:32PM CDT
Spectranetics (NASDAQ:SPNC) traded in a range yesterday that spanned from a low of $16.56 to a high of $17.72. Yesterday, the shares gained 5.8%, which took the trading range above the 3-day high of $17.39 on volume of 534,000 shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
SPNC: 23.16 (-0.02)

Spectranetics to Present at the UBS Global Healthcare Conference
GlobeNewswire - Wed May 11, 3:00PM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today announced that Chief Financial Officer Stacy McMahan will be presenting at the UBS Global Healthcare Conference on May 25, 2016, at the Grand Hyatt in New York City.
SPNC: 23.16 (-0.02)

Spectranetics reports 1Q loss
Automated Insights - Thu Apr 28, 6:28PM CDT
COLORADO SPRINGS, Colo. (AP) _ The Spectranetics Corp. (SPNC) on Thursday reported a loss of $17.3 million in its first quarter.
SPNC: 23.16 (-0.02)

Spectranetics Achieves First Quarter 2016 Revenue of $62.9 million
GlobeNewswire - Thu Apr 28, 3:01PM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today reported financial results for the three months ended March 31, 2016. Highlights of the quarter, all compared with the three months ended March 31, 2015, include:
SPNC: 23.16 (-0.02)

Downgrade Alert for Spectranetics (SPNC)
Comtex SmarTrend(R) - Wed Apr 27, 3:15AM CDT
Spectranetics (NASDAQ:SPNC) was downgraded from Buy to Hold at Craig-Hallum today. The stock closed yesterday at $16.91 on volume of 1.8 million shares, above average daily volume of 473,000. The Spectranetics Corporation develops, manufactures, markets, and distributes its technology for interventional cardiovascular therapy. The Company's CVX-300 excimer laser system is used in applications such as coronary angioplasty and the removal of pacemaker leads. Spectranetics is also developing other applica- tions in restenosis stents and peripheral vascular applications.
SPNC: 23.16 (-0.02)

12-Month Interim ILLUMENATE Global Study Data Presented on Spectranetics' Stellarex drug-coated balloon at Charing Cross
GlobeNewswire - Tue Apr 26, 5:30AM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today announced that Professor Thomas Zeller presented 12-month interim data from the ILLUMENATE Global Study at the Charing Cross Symposium in London, England. The ILLUMENATE Global Study is a prospective, multicenter, single-arm study designed to assess the clinical performance of the Stellarex(TM) drug-coated balloon (DCB) in the superficial femoral and popliteal arteries.
SPNC: 23.16 (-0.02)

Spectranetics to Host First Quarter 2016 Conference Call on April 28, 2016
GlobeNewswire - Thu Apr 07, 3:00PM CDT
The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release first quarter 2016 financial results after the market close on Thursday, April 28, 2016. Company management will host a conference call beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on Thursday, April 28, 2016 to discuss results and provide a general business update.
SPNC: 23.16 (-0.02)

Spectranetics Names Udo Scheiner as Senior Vice President, International Operations
GlobeNewswire - Thu Mar 24, 3:00PM CDT
The Spectranetics Corporation (NASDAQ:SPNC) today announced that Udo Scheiner has been named Senior Vice President, International Operations, effective March 23, 2016. In this role, Mr. Scheiner will report directly to Scott Drake, President and Chief Executive Officer, and will be based in Zurich, Switzerland.
SPNC: 23.16 (-0.02)

QT Vascular Announces Another Positive Outcome in Litigation with Spectranetics/Angioscore
PR Newswire - Wed Feb 10, 8:07PM CST
QT Vascular Ltd., together with its subsidiaries (the "Company" or "QT Vascular", and together with its subsidiaries, the "Group" , is pleased to provide an update in its ongoing litigation with AngioScore, Inc. ("ÄngioScore" (now owned by Spectranetics Corporation (NASDAQ: SPNC)).
SPNC: 23.16 (-0.02)

Spectranetics to Hold 2015 Fourth Quarter Financial Results Conference Call on February 25, 2016
GlobeNewswire - Tue Feb 09, 3:08PM CST
The Spectranetics Corporation (Nasdaq:SPNC) today announced that the Company will release 2015 fourth quarter financial results after market close on Thursday, February 25, 2016. Company management will host an investment-community conference call beginning at 2:30 p.m. Mountain Time (4:30 p.m. Eastern Time) on Thursday, February 25 to discuss those results and to answer questions.
SPNC: 23.16 (-0.02)

Spectranetics passes US FDA 510(k) clearance for the cardiac life-saving technology Bridge Occlusion Balloon
M2 - Tue Feb 09, 5:27AM CST
Medical devices company Spectranetics Corporation (NasdaqGS:SPNC) revealed on Monday that it has received US Food and Drug Administration (FDA) Premarket Notification 510(k) clearance for its Bridge Occlusion Balloon for the safety, stability and procedural control in cardiac lead extraction procedures.
SPNC: 23.16 (-0.02)

US Market for Peripheral Vascular Devices and Accessories Report Suite 2016
M2 - Fri Jan 15, 4:30AM CST
Research and Markets (http://www.researchandmarkets.com/research/l5kqqx/us_market_for) has announced the addition of the "US Market for Peripheral Vascular Devices and Accessories Report Suite - 2016" report to their offering. Growth in the value of the U.S. market for peripheral vascular devices is being driven by the aging U.S. population, improving public awareness of peripheral arterial disease (PAD) and improvements in medical device technology. The transcatheter embolization device market is expected to be the fastest growing segment, increasing at a CAGR in the mid-to-high teens over the forecast period. The strong growth in this market will be a result of the increase in usage of radiolabeled and drug-eluting beads as well as the increasing penetration rate of detachable embolization coils. The U.S. market for peripheral vascular devices includes stents, percutaneous transluminal angioplasty (PTA) balloon catheters, atherectomy devices, chronic total occlusion (CTO) devices, embolic protection devices (EPDs), stent grafts, surgical grafts, thrombectomy devices, inferior vena cava filters (IVCFs), catheters, guidewires, introducer sheaths, vascular closure devices (VCDs) and transcatheter embolization devices. Many of these devices can be used for treating either coronary arterial disease or peripheral arterial disease (PAD). However, only devices used for peripheral procedures are included in this report. Key Topics Covered: 1 Overview 2 Research Methodology 3 U.S. Peripheral Vascular Device Market Overview 4 Procedure Numbers 5 Peripheral Vascular Stent Market 6 PTA Balloon Catheter Market 7 Atherectomy Device Market 8 Chronic Total Occlusion Device Market 9 Embolic Protection Device Market 10 Stent Graft Market 11 Surgical Graft Market 12 Thrombectomy Device Market 13 Inferior Vena Cava Filter Market 14 Diagnostic And Interventional Catheter Market 15 Diagnostic And Interventional Guidewire Market 16 Introducer Sheath Market Companies Mentioned - Medtronic - W.L. Gore - Cook Medical - Boston Scientific - C.R. Bard - Abbott Laboratories - Cardinal Health - Terumo - Endologix - Cardiovascular Systems Inc. - Sirtex - Maquet - BTG - St. Jude Medical - Spectranetics - Teleflex Medical - Advanced Vascular Dynamics - AngioSlide - Arstasis - C.R. Bard - Creagh Medical - EndoShape - HemCon Medical Technologies - Merit Medical Systems, Inc. - Morris Innovative, Inc. - Nantec Medical - Penumbra - Pfizer - Silk Road Medical - Teleflex Medical - Terumo - TriReme Medical - TZ Medical - Vascular Flow Technologies - W.L. Gore For more information visit http://www.researchandmarkets.com/research/l5...market_for
BSX: 24.43 (+0.15), SPNC: 23.16 (-0.02), ABT: 45.29 (+0.54), MDT: 88.06 (+0.43), CSII: 19.50 (-0.11), STJ: 83.73 (+0.69), MMSI: 23.60 (+0.16)

Spectranetics Shareholders and Former Employees Are Encouraged to Contact Court Appointed Lead Counsel Glancy Prongay & Murray in Securities Class Action
BusinessWire - Mon Jan 11, 11:32AM CST
Glancy Prongay & Murray LLP ("GPM" announces that it has been appointed Co-Lead Counsel in the securities class action against The Spectranetics Corporation ("Spectranetics" or the "Company" (NASDAQ: SPNC) and certain executive officers of the Company, currently pending in the United States District Court for the District of Colorado - Ellis v. The Spectranetics Corporation, et al., No. 15-cv-01857-KLM.
SPNC: 23.16 (-0.02)

Robbins Arroyo LLP is Investigating the Officers and Directors of The Spectranetics Corporation (SPNC) on Behalf of Shareholders
BusinessWire - Wed Dec 30, 2:09PM CST
Shareholder rights law firm Robbins Arroyo LLP is investigating claims that certain officers and directors of The Spectranetics Corporation (NASDAQGS: SPNC) violated the Securities Exchange Act of 1934 by making materially false and misleading statements about Spectranetics' business prospects. Spectranetics, together with its subsidiaries, develops, manufactures, markets, and distributes single-use medical devices used in minimally invasive procedures in the cardiovascular system.
SPNC: 23.16 (-0.02)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Radiate Holdco's Q3 Results: What We Know Now

Updated Category News Views 69

Digging Into Third Quarter Highlights Radiate Holdco, LLC has just thrown its third-quarter financial hat into the ring, stirring up some interest in the world of FLFO secured notes and senior notes. The folks in Princeton, N.J., sure know how to keep things exclusive—this intel is only for those holding their Notes or in the pretty exclusive club of qualified...

Continue Reading
Cognito Unveils Phase 3 Results for Alzheimer Treatment

Updated Category News Views 255

Charting New Waters in Alzheimer's Treatment Well, here's one for the books, folks. Cognito Therapeutics just tossed their latest Phase 3 results from their so-called HOPE study into the ring. We're talking about Spectris AD, a non-drug, at-home gizmo that aims to be the next big thing for Alzheimer's. Yeah, the study didn't exactly hit a home run with the primary...

Continue Reading
Teledyne LeCroy Drives AI Scale-up with New UALink

Updated Category News Views 69

Pushing the Boundaries of AI Infrastructure Teledyne LeCroy is shaking things up with their latest innovation—the Xena Z2244 Ultra Accelerator Link™ Traffic Generator, a tool that promises to turbocharge validation systems for AI and HPC scale-up infrastructure. If you're dealing with the nuts and bolts of next-gen networks, this one's worth your attention. Setting a...

Continue Reading
RBC Grabs Top Honors for Sustainable Investing Leadership

Updated Category News Views 136

A New Feather in RBC's Cap RBC Wealth Management has racked up more accolades, crowned as the Best Private Bank in Canada and celebrated for its prowess in impact and sustainable investing on the global stage. These distinctions flew in courtesy of the PWM Global Private Banking Awards—a heavyweight recognition in the wealth management world. Award Winning Strategy in...

Continue Reading
Nauticus Robotics Dive into Defense & UAE Moves

Updated Category News Views 131

Charting New Waters: Defense and UAE Focus Looking at Nauticus Robotics lately, it feels like they're finally getting the hang of balancing their defense play and UAE expansions. This quarter they're coming out swinging, dropping some fine numbers mixed with a slew of strategic moves that got me thinking twice about their place in the subsea robotics world. Financial...

Continue Reading
Gary Brecka's Longevity Centers Set to Launch with Impact

Updated Category News Views 148

A Footprint of Longevity in the Making It's not every day you see a name like Daymond John, of Shark Tank fame, getting his hands into the business of human longevity. But here we are, with Gary Brecka's Ultimate Longevity Center (ULC) getting ready to open its first centers come January 2027, in Arizona, Colorado, Florida, and Southern California. More than 300 U.S....

Continue Reading
Fold Health's AI: Revolutionizing Patient Care Dynamics

Updated Category News Views 140

AI's Role in Healthcare: From Insight to Action Healthcare's got a resource issue, plain and simple. It's like trying to fill a bathtub with a hole in it—clinicians are swamped, burnout is high, and patients aren't getting the attention they need. Enter Fold Health's AI operating layer, launched with the ambition to realign the equation. Not Just Another Tech Buzzword...

Continue Reading
Shareholder Alert: Investigation Looms Over GDYN

Updated Category News Views 63

Grid Dynamics Under Legal Scrutiny There’s nothing quite like waking up to find your pick embroiled in an investigation. Grid Dynamics Holdings, Inc. (NASDAQ: GDYN) is on the radar, with law firm Levi & Korsinsky diving headfirst into potential infractions of fiduciary duties by some of the company’s top brass. The Lowdown on the Investigation This whole circus was...

Continue Reading
Monotype Unveils Font Tool for Adobe: A Game-Changer?

Updated Category News Views 165

Monotype Connect: Fonts Meet Convenience Imagine fighting through a blizzard with a flashlight. That's how designers juggle fonts without a central tool. Well, Monotype's got them covered with the new Connect panel for Adobe apps—a beacon of efficiency spotted at Adobe MAX 2026 in Miami Beach. Efficiency and Brand Unity: Partners in Design Now, here’s why this isn’t...

Continue Reading
Lennar Faces Legal Heat Over Alleged Misleading Statements

Updated Category News Views 120

Rumbling Legal Drama with Lennar Corporation Every trader knows the uneasy feeling when a stock you're eyeing takes a surprising nosedive on some legal muck coming out of the woodwork. Well, it's Lennar Corporation's turn in the spotlight for all the wrong reasons. They're getting slapped with a class action lawsuit by investors claiming the company pulled a fast one...

Continue Reading

Top 5 Most Recently Viewed Articles

Radiant Striping's Community Commitment through Service Initiatives

Updated Category News Views 144

Radiant Striping's Charitable Impact on the Community Radiant Striping, a veteran-owned company, is making waves in their community through generous donations of parking lot striping and other services to local organizations. It's not just about the perfect paint job; it’s about building safer, more welcoming spaces for families and visitors alike. A Mission Rooted in...

Continue Reading
Supernus Pharmaceuticals Announces Participation in Key Healthcare Event

Updated Category News Views 86

Supernus Pharmaceuticals' Participation in the Healthcare Conference Supernus Pharmaceuticals, Inc. (Nasdaq: SUPN), a dedicated biopharmaceutical company, is excited to announce its upcoming participation in a significant healthcare conference. The conference will take place soon, and prominent figures from the company, including Jack Khattar, President and CEO, are set...

Continue Reading
CTC Celebrated as Top Veteran-Friendly Employer in 2024

Updated Category News Views 70

Concurrent Technologies Corporation Recognized in 2024 Concurrent Technologies Corporation (CTC) is thrilled to announce its inclusion in the U.S. Veterans Magazine’s Top Veteran-Friendly Employers list for 2024. This achievement marks the fourth consecutive year that CTC has received this important recognition. How U.S. Veterans Magazine Evaluates Employers Each year,...

Continue Reading
Chimerix Announces Inducement Grant of Stock Options

Updated Category News Views 188

Chimerix Announces Inducement Grant of Stock Options Chimerix (NASDAQ:CMRX), a prominent biopharmaceutical company, has announced a notable inducement award for a newly hired employee. This grant includes non-statutory stock options totaling 150,000 shares of the company's common stock, underscoring Chimerix's dedication to attracting top talent in the competitive biotech...

Continue Reading
EarFun Showcases Cutting-Edge Wireless Audio Innovations

Updated Category News Views 620

Discover the Latest Innovations from EarFun at CES 2025 EarFun, a prominent name in wireless audio technology, is set to unveil a range of cutting-edge products that will redefine the audio experience. Their participation in CES 2025 promises to highlight significant advancements that cater to diverse listening needs. Innovative AI-Powered Features The spotlight will be...

Continue Reading